| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 56 | +51.79% | +1.98% | -0.69% | +2.67% | -1.61% | 1.94 |
| 14d | 56 | +55.36% | +5.19% | +1.60% | +3.59% | -0.27% | 1.94 |
| 30d | 56 | +42.86% | +7.69% | +3.38% | +4.31% | -3.44% | 1.64 |
| 60d | 56 | +53.57% | +2.50% | +3.24% | -0.74% | -8.80% | -0.25 |
| 90d | 56 | +55.36% | +2.07% | +6.47% | -4.40% | -14.10% | -0.80 |
| 180d | 56(3 pending) | +54.72% | -1.51% | +14.79% | -16.31% | -21.41% | -3.47 |
| 1y | 56(8 pending) | +54.17% | +8.70% | +32.61% | -23.91% | -37.21% | -3.09 |
| 2y | 56(12 pending) | +59.09% | +0.34% | +46.67% | -46.33% | -66.57% | -4.30 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 195,952 | — | — | 195,952 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 97,997 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 143,750 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 234,411 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 372,815 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 206,250 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 87,108 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 36,047 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 100,538 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 425,968 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 287,500 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 472,065 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 97,976 | — | — | 97,976 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 20,862 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 195,952 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 87,108 | — | — | 87,108 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 273,312 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 131,093 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 273,779 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 143,750 | — | — | 143,750 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 104,834 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 150,000 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 300,000 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 170,400 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 97,976 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 64,869 | — | — | 372,815 | Mar 11, 2026 | Mar 13, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 64,869 | — | — | 425,968 | Mar 11, 2026 | Mar 13, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 8,840 | — | — | 0 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 8,840 | $3.76 | $33.2K | 490,837 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 195,952 | — | — | 481,997 | Jan 28, 2026 | Jan 29, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 27,192 | $21.77 | $591.8K | 286,045 | Jan 22, 2026 | Jan 23, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 8,182 | $19.79 | $161.9K | 313,237 | Jan 20, 2026 | Jan 21, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 10,186 | $22.19 | $226.0K | 321,419 | Jan 13, 2026 | Jan 15, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 49,963 | $28.39 | $1.42M | 307,946 | Aug 28, 2025 | Aug 29, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 175,037 | $28.19 | $4.93M | 357,909 | Aug 27, 2025 | Aug 29, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 8,997 | $4.31 | $38.8K | 351,330 | Jul 17, 2025 | Jul 18, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 19,725 | $20.21 | $398.7K | 331,605 | Jul 17, 2025 | Jul 18, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 8,997 | — | — | 100,538 | Jul 17, 2025 | Jul 18, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 800 | — | — | 109,535 | Jul 15, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 800 | $4.31 | $3.4K | 344,233 | Jul 15, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,900 | $20.09 | $38.2K | 342,333 | Jul 15, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 65,203 | $4.31 | $281.0K | 480,898 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 65,203 | — | — | 110,335 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 137,465 | $20.19 | $2.77M | 343,433 | Jul 14, 2025 | Jul 16, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 287,500 | $19.39 | $5.57M | 287,500 | Jun 9, 2025 | Jun 11, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,824 | $29.52 | $83.4K | 415,695 | Jan 29, 2025 | Jan 30, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 13,551 | $30.43 | $412.3K | 418,519 | Jan 22, 2025 | Jan 23, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 130,662 | — | — | 432,070 | Jan 21, 2025 | Jan 21, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 6,007 | $29.96 | $180.0K | 301,408 | Jan 17, 2025 | Jan 21, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 6,247 | $28.70 | $179.3K | 307,415 | Jan 13, 2025 | Jan 14, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 182,146 | — | — | 472,065 | Nov 1, 2024 | Nov 1, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 50,000 | — | — | 8,840 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 413 | $65.68 | $27.1K | 313,662 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 116,512 | $64.92 | $7.56M | 314,075 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 200,000 | $4.31 | $862.0K | 563,662 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 62,503 | $64.26 | $4.02M | 430,587 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 28,868 | $62.21 | $1.80M | 534,794 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 50,000 | $3.76 | $188.0K | 363,662 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 41,704 | $62.96 | $2.63M | 493,090 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 200,000 | — | — | 175,538 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,962 | $67.77 | $268.5K | 313,662 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,843 | $64.14 | $182.3K | 317,624 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 13,431 | $65.00 | $873.0K | 320,467 | Jan 22, 2024 | Jan 23, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 72,094 | — | — | 341,749 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 7,851 | $66.81 | $524.5K | 333,898 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 104,834 | $66.30 | $6.95M | 104,834 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $48.80 | $244.0K | 269,655 | Nov 21, 2023 | Nov 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 150,000 | — | — | 804,211 | Sep 19, 2023 | Sep 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 150,000 | — | — | 274,655 | Sep 19, 2023 | Sep 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 10,284 | $42.44 | $436.5K | 424,655 | Sep 1, 2023 | Sep 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 300,000 | — | — | 0 | Sep 1, 2023 | Sep 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 300,000 | $2.67 | $801.0K | 574,655 | Sep 1, 2023 | Sep 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 139,716 | $41.70 | $5.83M | 434,939 | Sep 1, 2023 | Sep 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 20,000 | — | — | 274,655 | May 24, 2023 | May 25, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 20,000 | — | — | 654,211 | May 24, 2023 | May 25, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 20,000 | $2.67 | $53.4K | 294,655 | May 17, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 20,000 | — | — | 300,000 | May 17, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 7,528 | $87.02 | $655.1K | 276,775 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 934 | $83.17 | $77.7K | 303,721 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,007 | $85.90 | $258.3K | 284,303 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,120 | $87.67 | $185.9K | 274,655 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 14,611 | $85.01 | $1.24M | 287,310 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,000 | $2.67 | $80.1K | 304,655 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,000 | — | — | 320,000 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 1,800 | $83.85 | $150.9K | 301,921 | May 16, 2023 | May 18, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 382,946 | — | — | 274,655 | Apr 27, 2023 | Apr 28, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 382,946 | — | — | 382,946 | Apr 27, 2023 | Apr 28, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 20,000 | — | — | 350,000 | Apr 19, 2023 | Apr 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 20,000 | $2.67 | $53.4K | 657,601 | Apr 19, 2023 | Apr 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,000 | — | — | 370,000 | Apr 18, 2023 | Apr 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,000 | $2.67 | $80.1K | 667,601 | Apr 18, 2023 | Apr 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 30,000 | $82.02 | $2.46M | 637,601 | Apr 18, 2023 | Apr 20, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 26,990 | — | — | 634,211 | Apr 5, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 26,990 | — | — | 637,601 | Apr 5, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 380,000 | — | — | 664,591 | Apr 4, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 380,000 | — | — | 607,221 | Apr 4, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 227,221 | — | — | 1,044,591 | Apr 3, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 227,221 | — | — | 227,221 | Apr 3, 2023 | Apr 5, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 100,000 | $3.76 | $376.0K | 1,264,591 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 7,221 | $13.85 | $100.0K | 1,271,812 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 20,000 | — | — | 400,000 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 20,000 | $2.67 | $53.4K | 1,164,591 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 100,000 | — | — | 58,840 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 7,221 | — | — | 273,779 | Mar 22, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,000 | $2.67 | $80.1K | 1,174,591 | Mar 21, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,000 | — | — | 420,000 | Mar 21, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,000 | $62.74 | $1.88M | 1,144,591 | Mar 21, 2023 | Mar 23, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 100,000 | $3.76 | $376.0K | 1,144,591 | Feb 27, 2023 | Mar 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 100,000 | — | — | 158,840 | Feb 27, 2023 | Mar 1, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 13,908 | — | — | 1,046,193 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 1,602 | $58.50 | $93.7K | 1,044,591 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,728 | — | — | 19,728 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,958 | $51.21 | $202.7K | 1,032,285 | Feb 10, 2023 | Feb 14, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,879 | $52.77 | $151.9K | 1,036,243 | Jan 27, 2023 | Jan 30, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 9,453 | $52.05 | $492.0K | 1,039,122 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 83,447 | — | — | 1,048,575 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 131,093 | $52.66 | $6.90M | 131,093 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 6,688 | — | — | 273,312 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 28,200 | — | — | 450,000 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 15,000 | $3.76 | $56.4K | 986,640 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,751 | $51.97 | $194.9K | 989,577 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 15,000 | — | — | 258,840 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 24,449 | $52.07 | $1.27M | 965,128 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 6,688 | $14.95 | $100.0K | 993,328 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 28,200 | $2.67 | $75.3K | 971,640 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 75,000 | — | — | 0 | Apr 25, 2022 | Jan 17, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 12,500 | — | — | 943,440 | Apr 25, 2022 | Dec 21, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,523 | $47.12 | $118.9K | 955,940 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,024 | $38.59 | $78.1K | 1,338,463 | Jan 28, 2022 | Jan 31, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 106,244 | — | — | 1,340,487 | Jan 21, 2022 | Jan 25, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 150,672 | — | — | 150,672 | Jan 21, 2022 | Jan 25, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 14,410 | $4.31 | $62.1K | 1,234,243 | Jul 21, 2021 | Jul 22, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 14,410 | — | — | 375,538 | Jul 21, 2021 | Jul 22, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,523 | $47.72 | $120.4K | 1,219,833 | Feb 10, 2021 | Feb 11, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 1,209,856 | Jan 28, 2021 | Jan 29, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 1,222,356 | Jan 28, 2021 | Jan 29, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 28, 2021 | Jan 29, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Jan 28, 2021 | Jan 29, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 31,992 | — | — | 389,948 | Jan 27, 2021 | Jan 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 39,785 | $3.76 | $149.6K | 1,152,864 | Jan 27, 2021 | Jan 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 39,785 | — | — | 273,840 | Jan 27, 2021 | Jan 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 31,992 | $4.31 | $137.9K | 1,184,856 | Jan 27, 2021 | Jan 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $52.16 | $260.8K | 1,113,079 | Dec 15, 2020 | Dec 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 40,000 | — | — | 313,625 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 40,000 | $3.76 | $150.4K | 1,118,079 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $39.38 | $196.9K | 1,078,079 | Nov 16, 2020 | Nov 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $34.46 | $172.3K | 1,083,079 | Oct 15, 2020 | Oct 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $30.96 | $154.8K | 1,088,079 | Sep 15, 2020 | Sep 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,457 | $30.00 | $103.7K | 1,093,079 | Aug 20, 2020 | Aug 21, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 1,543 | $30.00 | $46.3K | 1,096,536 | Aug 18, 2020 | Aug 19, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $32.12 | $160.6K | 1,098,079 | Jul 15, 2020 | Jul 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $30.21 | $151.1K | 1,103,079 | Jun 15, 2020 | Jun 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $29.92 | $149.6K | 1,108,079 | May 15, 2020 | May 19, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $29.77 | $148.8K | 1,113,079 | Apr 15, 2020 | Apr 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,637 | $2.14 | $65.6K | 1,083,704 | Mar 17, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | — | — | 0 | Mar 17, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,192 | $21.57 | $47.3K | 1,084,404 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 2,108 | $20.73 | $43.7K | 1,086,596 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,637 | $2.14 | $65.6K | 1,088,704 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 700 | $22.29 | $15.6K | 1,083,704 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 3,212 | $22.28 | $71.6K | 1,053,367 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 15,065 | $21.58 | $325.1K | 1,056,579 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 300 | $23.86 | $7.2K | 1,053,067 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | — | — | 30,637 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 12,060 | $20.69 | $249.6K | 1,071,644 | Mar 16, 2020 | Mar 17, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,637 | $2.14 | $65.6K | 1,058,067 | Feb 19, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | — | — | 61,274 | Feb 19, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,637 | $2.14 | $65.6K | 1,063,067 | Feb 18, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $40.67 | $203.3K | 1,027,430 | Feb 18, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | $40.66 | $1.25M | 1,032,430 | Feb 18, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | — | — | 91,911 | Feb 18, 2020 | Feb 20, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 206,250 | — | — | 206,250 | Feb 10, 2020 | Feb 12, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 34,375 | — | — | 1,066,805 | Feb 10, 2020 | Feb 12, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,637 | $2.14 | $65.6K | 1,032,430 | Jan 16, 2020 | Jan 21, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,637 | — | — | 122,548 | Jan 16, 2020 | Jan 21, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 4,562 | $42.55 | $194.1K | 1,006,793 | Jan 15, 2020 | Jan 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 30,638 | $2.14 | $65.6K | 1,001,793 | Jan 15, 2020 | Jan 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 5,000 | $41.47 | $207.3K | 1,001,793 | Jan 15, 2020 | Jan 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 26,076 | $42.16 | $1.10M | 1,011,355 | Jan 15, 2020 | Jan 16, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 30,638 | — | — | 153,185 | Jan 15, 2020 | Jan 16, 2020 ↗ | View → |